Skip to content

Liraglutide clinical trials: 262 trials

Page 1 of 6

Read 262 Liraglutide clinical trials with posted results or linked papers with results in PepBank.

  1. Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

    NCT01179048 · Phase 3 · Completed

    Posted results

  2. A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

    NCT01794143 · Phase 3 · Completed

    Posted results

  3. Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

    NCT01272219 · Phase 3 · Completed

    Posted results

  4. Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

    NCT02730377 · Phase 4 · Completed

    Posted results

  5. Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

    NCT01336023 · Phase 3 · Completed

    Posted results

  6. The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

    NCT01836523 · Phase 3 · Completed

    Posted results

  7. To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

    NCT00318461 · Phase 3 · Completed

    Posted results

  8. A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

    NCT02501161 · Phase 3 · Completed

    Posted results

  9. The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

    NCT00856986 · Phase 3 · Completed

    Posted results

  10. Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure

    NCT01117350 · Phase 4 · Completed

    Posted results

  11. Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

    NCT00614120 · Phase 3 · Completed

    Posted results

  12. Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

    NCT01029886 · Phase 3 · Completed

    Posted results

  13. Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

    NCT01272232 · Phase 3 · Completed

    Posted results

  14. A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

    NCT01128894 · Phase 3 · Completed

    Posted results

  15. The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes

    NCT02098395 · Phase 3 · Completed

    Posted results

  16. A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

    NCT02607306 · Phase 3 · Completed

    Posted results

  17. To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

    NCT00294723 · Phase 3 · Terminated

    Posted results

  18. A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

    NCT03172494 · Phase 3 · Completed

    Posted results

  19. Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

    NCT02863419 · Phase 3 · Completed

    Posted results

  20. The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

    NCT00700817 · Phase 3 · Completed

    Posted results

  21. Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

    NCT01296412 · Phase 3 · Completed

    Posted results

  22. A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

    NCT02505334 · Phase 3 · Completed

    Posted results

  23. A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

    NCT01624259 · Phase 3 · Completed

    Posted results

  24. Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes

    NCT03191396 · Phase 3 · Completed

    Posted results

  25. A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

    NCT01952145 · Phase 3 · Completed

    Posted results

  26. Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

    NCT02787551 · Phase 3 · Completed

    Posted results

  27. A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

    NCT02420262 · Phase 3 · Completed

    Posted results

  28. A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

    NCT05579249 · Phase 4 · Completed

    Posted results

  29. A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

    NCT01733758 · Phase 3 · Completed

    Posted results

  30. A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

    NCT01558271 · Phase 3 · Completed

    Posted results

  31. Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

    NCT00518882 · Phase 3 · Completed

    Posted results

  32. A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

    NCT03175120 · Phase 3 · Completed

    Posted results

  33. The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

    NCT01617434 · Phase 3 · Completed

    Posted results

  34. The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

    NCT01676116 · Phase 3 · Completed

    Posted results

  35. The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy

    NCT01618162 · Phase 3 · Completed

    Posted results

  36. Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

    NCT00781937 · Phase 3 · Completed

    Posted results

  37. A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

    NCT02773368 · Phase 3 · Completed

    Posted results

  38. A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

    NCT02298192 · Phase 3 · Completed

    Posted results

  39. A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes

    NCT01392573 · Phase 3 · Completed

    Posted results

  40. Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

    NCT01388361 · Phase 3 · Completed

    Posted results

  41. Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

    NCT01907854 · Phase 4 · Completed

    Posted results

  42. Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes

    NCT01973231 · Phase 4 · Completed

    Posted results

  43. Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    NCT00393718 · Phase 3 · Completed

    Posted results

  44. Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

    NCT02963922 · Phase 3 · Completed

    Posted results

  45. Saxenda in Obesity Services (STRIVE Study)

    NCT03036800 · Phase 4 · Completed

    Posted results

  46. The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

    NCT02008682 · Phase 4 · Completed

    Posted results

  47. Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

    NCT01512108 · Phase 3 · Completed

    Posted results

  48. Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea

    NCT01557166 · Phase 3 · Completed

    Posted results

  49. The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

    NCT01664247 · Phase 3 · Completed

    Posted results

  50. Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

    NCT01917656 · Phase 4 · Completed

    Posted results

How PepBank reports evidence